IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products: Monocyte inhibition

Ana G. Ageitos, Rakesh K. Singh, Kazuhiko Ino, Ibrahim Ozerol, Stefano Tarantolo, Elizabeth K. Reed, James E. Talmadge

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The expansion of T and natural killer (NK) cells in growth factor-mobilized peripheral blood stem cell (PSC) products with interleukin-2 (IL-2) requires a reduction in monocyte frequency. Monocytes are enriched with stem cells during apheresis and, in this series of growth factor-mobilized PSC products from breast cancer patients, represented 36 ± 6% of the cells in the product. Immunophenotyping studies revealed that monocytes inhibited the proliferation of NK cells (CD56+ and CD3 CDS+ CD56+ cells) and T cells (CD3+, CD4+, and CD8+ cells) during IL-2 co-culture for 7, 14, or 21 days. A reduction in monocytes resulted in 61-fold expansion of CD3 CD8+ CD56+ cells compared with a 3.7-fold increase of CD3+ cells by day 21. In addition, following IL-2 co-culture, cells from PSC products with a reduced frequency of monocytes had a significantly increased T cell mitogenic response and NK cell activity in PSC products compared with intact products. We suggest that monocytes inhibit the IL-2-dependent proliferation and augmented function of NK and T cells from growth factor-mobilized PSC products.

Original languageEnglish (US)
Pages (from-to)409-417
Number of pages9
JournalJournal of Immunotherapy
Volume21
Issue number6
DOIs
StatePublished - Jan 1 1998

Fingerprint

Natural Killer T-Cells
Interleukin-2
Monocytes
Intercellular Signaling Peptides and Proteins
Coculture Techniques
Natural Killer Cells
T-Lymphocytes
Immunophenotyping
Blood Component Removal
Peripheral Blood Stem Cells
Stem Cells
Breast Neoplasms

Keywords

  • Immunophenotype
  • Interleukin-2
  • Monocytes
  • Natural killer cells
  • Suppression
  • T cells
  • Tolerance

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology
  • Cancer Research

Cite this

IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products : Monocyte inhibition. / Ageitos, Ana G.; Singh, Rakesh K.; Ino, Kazuhiko; Ozerol, Ibrahim; Tarantolo, Stefano; Reed, Elizabeth K.; Talmadge, James E.

In: Journal of Immunotherapy, Vol. 21, No. 6, 01.01.1998, p. 409-417.

Research output: Contribution to journalArticle

@article{ff0c10562e9f4f17934a3a3878bb8f0d,
title = "IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products: Monocyte inhibition",
abstract = "The expansion of T and natural killer (NK) cells in growth factor-mobilized peripheral blood stem cell (PSC) products with interleukin-2 (IL-2) requires a reduction in monocyte frequency. Monocytes are enriched with stem cells during apheresis and, in this series of growth factor-mobilized PSC products from breast cancer patients, represented 36 ± 6{\%} of the cells in the product. Immunophenotyping studies revealed that monocytes inhibited the proliferation of NK cells (CD56+ and CD3− CDS+ CD56+ cells) and T cells (CD3+, CD4+, and CD8+ cells) during IL-2 co-culture for 7, 14, or 21 days. A reduction in monocytes resulted in 61-fold expansion of CD3− CD8+ CD56+ cells compared with a 3.7-fold increase of CD3+ cells by day 21. In addition, following IL-2 co-culture, cells from PSC products with a reduced frequency of monocytes had a significantly increased T cell mitogenic response and NK cell activity in PSC products compared with intact products. We suggest that monocytes inhibit the IL-2-dependent proliferation and augmented function of NK and T cells from growth factor-mobilized PSC products.",
keywords = "Immunophenotype, Interleukin-2, Monocytes, Natural killer cells, Suppression, T cells, Tolerance",
author = "Ageitos, {Ana G.} and Singh, {Rakesh K.} and Kazuhiko Ino and Ibrahim Ozerol and Stefano Tarantolo and Reed, {Elizabeth K.} and Talmadge, {James E.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1097/00002371-199811000-00002",
language = "English (US)",
volume = "21",
pages = "409--417",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products

T2 - Monocyte inhibition

AU - Ageitos, Ana G.

AU - Singh, Rakesh K.

AU - Ino, Kazuhiko

AU - Ozerol, Ibrahim

AU - Tarantolo, Stefano

AU - Reed, Elizabeth K.

AU - Talmadge, James E.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - The expansion of T and natural killer (NK) cells in growth factor-mobilized peripheral blood stem cell (PSC) products with interleukin-2 (IL-2) requires a reduction in monocyte frequency. Monocytes are enriched with stem cells during apheresis and, in this series of growth factor-mobilized PSC products from breast cancer patients, represented 36 ± 6% of the cells in the product. Immunophenotyping studies revealed that monocytes inhibited the proliferation of NK cells (CD56+ and CD3− CDS+ CD56+ cells) and T cells (CD3+, CD4+, and CD8+ cells) during IL-2 co-culture for 7, 14, or 21 days. A reduction in monocytes resulted in 61-fold expansion of CD3− CD8+ CD56+ cells compared with a 3.7-fold increase of CD3+ cells by day 21. In addition, following IL-2 co-culture, cells from PSC products with a reduced frequency of monocytes had a significantly increased T cell mitogenic response and NK cell activity in PSC products compared with intact products. We suggest that monocytes inhibit the IL-2-dependent proliferation and augmented function of NK and T cells from growth factor-mobilized PSC products.

AB - The expansion of T and natural killer (NK) cells in growth factor-mobilized peripheral blood stem cell (PSC) products with interleukin-2 (IL-2) requires a reduction in monocyte frequency. Monocytes are enriched with stem cells during apheresis and, in this series of growth factor-mobilized PSC products from breast cancer patients, represented 36 ± 6% of the cells in the product. Immunophenotyping studies revealed that monocytes inhibited the proliferation of NK cells (CD56+ and CD3− CDS+ CD56+ cells) and T cells (CD3+, CD4+, and CD8+ cells) during IL-2 co-culture for 7, 14, or 21 days. A reduction in monocytes resulted in 61-fold expansion of CD3− CD8+ CD56+ cells compared with a 3.7-fold increase of CD3+ cells by day 21. In addition, following IL-2 co-culture, cells from PSC products with a reduced frequency of monocytes had a significantly increased T cell mitogenic response and NK cell activity in PSC products compared with intact products. We suggest that monocytes inhibit the IL-2-dependent proliferation and augmented function of NK and T cells from growth factor-mobilized PSC products.

KW - Immunophenotype

KW - Interleukin-2

KW - Monocytes

KW - Natural killer cells

KW - Suppression

KW - T cells

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0031759379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031759379&partnerID=8YFLogxK

U2 - 10.1097/00002371-199811000-00002

DO - 10.1097/00002371-199811000-00002

M3 - Article

C2 - 9807735

AN - SCOPUS:0031759379

VL - 21

SP - 409

EP - 417

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 6

ER -